Singapore markets closed

Giant Biogene Holding Co., Ltd. (2367.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
47.950+0.100 (+0.21%)
At close: 04:08PM HKT

Giant Biogene Holding Co., Ltd.

No. 1855, Shanglin Yuan
7th Road Chang’an District
Xi’an
China
86 29 8115 6502
https://www.xajuzi.com

Sector(s)Consumer Defensive
IndustryHousehold & Personal Products
Full-time employees1,164

Key executives

NameTitlePayExercisedYear born
Mr. Jianya YanCEO & Executive Chairman of the Board768.17kN/A1966
Ms. Huijuan ZhangCFO & Executive Director245.07kN/A1987
Dr. Daidi FanChief Scientific OfficerN/AN/A1967
Ms. Juan YeSenior VP & Executive Director969.28kN/A1972
Ms. Juan FangSenior VP & Executive Director971.47kN/A1974
Ms. Yajuan YanSenior Vice PresidentN/AN/A1970
Ms. Yubo YanChief Product Officer, Joint Company Secretary & Executive Director153.85kN/A1996
Mr. Zhiguang DuanSenior Vice PresidentN/AN/A1982
Ms. Wing Yan Yuen FCIS, FCSJoint Company SecretaryN/AN/A1970
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.

Corporate governance

Giant Biogene Holding Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.